Member

We have the best data in the world, and with that, we absolutely have the opportunity here to be the Silicon Valley of the life sciences world. My fear about that, which noble Lords have heard me say many times, is that, if we are too restrictive, all we will get is the offshoring of that research. As a result, we would lose out at a clinical level, because the clinical trials and everything that follows would not take place in our hospitals. As a result, we would not get the treatments as quickly, and we would lose out on the commercial value as well.